Jolanta Rabe‐jabłońska
#107,561
Most Influential Person Now
Jolanta Rabe‐jabłońska's AcademicInfluence.com Rankings
Download Badge
Psychology Biology
Jolanta Rabe‐jabłońska's Degrees
- PhD Psychology University of Warsaw
- Doctorate Psychiatry Medical University of Warsaw
Why Is Jolanta Rabe‐jabłońska Influential?
(Suggest an Edit or Addition)Jolanta Rabe‐jabłońska's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. (1993) (18554)
- [Anxiety disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association: diagnostic and statistical manual of mental disorders (DMS-IV -- options book]. (1994) (101)
- Oxidative stress in blood platelets from schizophrenic patients (2005) (95)
- The Oxidative Stress May be Induced by the Elevated Homocysteine in Schizophrenic Patients (2012) (78)
- Levels of serum total cholesterol and LDL-cholesterol in patients with major depression in acute period and remission. (2000) (76)
- Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration (2010) (44)
- Quetiapine, Olanzapine and Haloperidol Affect Human Plasma Lipid Peroxidation in vitro (2011) (40)
- The first- and second-generation antipsychotic drugs affect ADP-induced platelet aggregation (2010) (37)
- Diurnal profile of melatonin secretion in the acute phase of major depression and in remission. (2001) (33)
- Diurnal profile of melatonin concentrations in patients with major depression: relationship to the clinical manifestation and antidepressant treatment. (2001) (31)
- Obstetric complications and Apgar score in early-onset schizophrenic patients with prominent positive and prominent negative symptoms. (2001) (29)
- PORT (Programme of Recognition and Therapy): the first Polish recognition and treatment programme for patients with an at‐risk mental state (2015) (29)
- Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms (2014) (27)
- Gender influence in suicidal behaviour of Polish adolescents (2003) (27)
- Beta-glucan from Saccharomyces cerevisiae reduces plasma lipid peroxidation induced by haloperidol. (2011) (22)
- Obstetrical complications and Apgar score in subjects at risk of psychosis. (2014) (22)
- A 10-Week Memantine Treatment in Bipolar Depression: A Case Report. Focus on Depressive Symptomatology, Cognitive Parameters and Quality of Life (2013) (20)
- [The effectiveness of antidepressants in the treatment of chronic non-cancer pain--a review]. (2005) (20)
- Pegylated interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients. (2008) (17)
- Impact of lithium alone or in combination with haloperidol on oxidative stress parameters and cell viability in SH-SY5Y cell culture (2015) (15)
- Epicatechin Inhibits Human Plasma Lipid Peroxidation Caused by Haloperidol In Vitro (2012) (15)
- Augmentation of Antipsychotics with Electroconvulsive Therapy in Treatment-Resistant Schizophrenia Patients with Dominant Negative Symptoms: A Pilot Study of Effectiveness (2014) (13)
- Two grams of sarcosine in schizophrenia – is it too much? A potential role of glutamate-serotonin interaction (2014) (12)
- [Calcium balance and regulation in schizophrenic patients treated with second generation antipsychotics]. (2005) (12)
- The effects of the second generation antipsychotics and a typical neuroleptic on collagen-induced platelet aggregation in vitro. (2010) (11)
- [Trazodon--the antidepressant: mechanism of action and its position in the treatment of depression]. (2011) (11)
- [The prevalence od social phobia in representative group of adolescents from Lodz]. (2003) (10)
- [Psychotic disorders related with chronic use of mephedrone. Case report]. (2011) (10)
- Electroconvulsive therapy in patient with psychotic depression and multiple sclerosis (2014) (10)
- [Prevalence and type of dermatologic disorders in psychiatric patients treated with psychotropic drugs]. (2004) (9)
- [Decrease in mineral bone density in schizophrenic patients treated with 2nd generation antipsychotics]. (2005) (9)
- [A new draft of the mental disorders classification prepared by the American Psychiatric Association: diagnostic and statistical manual of mental disorders-IV, Options Book]. (1993) (8)
- [Clinical picture and duration of prodromal period of schizophrenia in adolescents]. (1999) (8)
- Temperament Traits and Preference for Surgical or Nonsurgical Specialties in Year 6 Medical Students (2014) (8)
- Olanzapine-Induced Triglyceride and Aminotransferase Elevations Without Weight Gain or Hyperglycemia Normalized After Switching to Aripiprazole (2014) (8)
- Medical Students Hierarchy of Values and Sense of Responsibility (2012) (8)
- [Obsessive-compulsive disorders in adolescents with diagnosed schizophrenia]. (2001) (7)
- [Results of long-term observation (3-11 years) of patients with dual diagnosis: body dysmorphic disorder and delusional disorder, somatic type]. (1998) (7)
- Therapeutic effects and tolerability of fluvoxamine treatment in adolescents with dysthymia. (2000) (7)
- Undiagnosed normal pressure hydrocephalus as a cause of diagnostic difficulties in a patient with depression. (2013) (6)
- The effects of the second generation antipsychotics and a typical neuroleptic on collagen-induced platelet aggregation in vitro (2010) (6)
- [Brain metabolism alterations in patients with anorexia nervosa observed in 1H-MRS]. (2004) (6)
- [Neurological soft signs as a candidate for endophenotype of schizophrenia]. (2014) (6)
- [Augmentation of antipsychotics with glycine may ameliorate depressive and extrapyramidal symptoms in schizophrenic patients--a preliminary 10-week open-label study]. (2013) (6)
- [Anorexia nervosa in adult women]. (2003) (5)
- P.3.a.018 Vitamin D deficiency and impaired parathormone metabolism as a risk factor of low bone mineral density in patients with diagnosis of schizophrenia treated with second generation antipsychotics (2006) (5)
- [Changes in positive and negative symptoms, general psychopathology in schizophrenic patients during augmentation of antipsychotics with glycine: a preliminary 10-week open-label study]. (2011) (5)
- Figural fluency and immediate visual memory in patients with at‐risk mental state for psychosis: empirical study (2015) (5)
- [Obsessive-compulsive disorder in girls with eating disorders]. (1996) (4)
- [Links between pain and depression]. (2005) (4)
- [Internal capsule integrity and its sex-related structural differences in early-onset schizophrenia - diffusion tensor imaging study]. (2015) (4)
- The risk of significant body weight gain and abdominal obesity during short-term treatment with olanzapine (2009) (4)
- [Before you diagnose a patient with a conversion disorder, perform a thorough general medical and neurological examination. Case study]. (2012) (4)
- Is There a Decline in Cognitive Functions After Combined Electroconvulsive Therapy and Antipsychotic Therapy in Treatment-Refractory Schizophrenia? (2015) (4)
- [CYP2D6 gene polymorphism in psychiatric patients resistant to standard pharmacotherapy]. (1999) (3)
- [Liaison between body dysmorphic disorder and eating disorders]. (1998) (3)
- [Olfactory dysfunctions in patients with schizophrenia]. (2007) (3)
- Evaluation of white matter structure changes, as assessed in tractography, and cognitive dysfunctions in patients with early onset schizophrenia and their first-degree relatives. (2017) (3)
- [Communication and speech disorders and their relationship with psychic development and mental disorders in 8 year old children from the Lódź area]. (2005) (3)
- [The metabolic syndrome and its components in participants of EUFEST]. (2008) (3)
- [The assessment of the mental state of patients during simultaneous treatment with psychotropic drugs, antipsychotics included, and bromocriptine]. (2008) (3)
- [Osteoporosis risk factors among patients with schizophrenia]. (2006) (3)
- [Cognitive disturbances observed in chronic hepatitis C patients during pegylated interferon alpha and ribavirin therapy]. (2008) (3)
- [Risk factors of schizophrenia development in patients with amphetamines dependence and psychosis (amphetamine-induced psychosis and schizophrenia), and without psychosis]. (2012) (3)
- [Opinions regarding the importance of body image disorders in the development and in the course of eating disorders]. (1997) (2)
- Impact of lithium alone or in combination with haloperidol on selected oxidative stress parameters in human plasma in vitro (2016) (2)
- P.3.c.017 Polish patients of the EUFEST study after 1 year antipsychotic treatment: drug discontinuation and metabolic syndrome parameters (2010) (2)
- [Significance of synaptic connectivity reduction for pathogenesis, clinical picture and course of schizophrenia]. (2003) (2)
- [Delusion of sex change and body dysmorphic disorder in clinical picture of paranoid schizophrenia--case reports]. (2010) (2)
- Effects of Lithium on Oxidative Stress (2015) (2)
- Relationship Between Oxidative Stress and Obsessive - Compulsive Disorder (2015) (2)
- [Prolactin secretion disturbances in schizophrenic patients treated with 2nd generation antipsychotics--risperidone and olanzapine]. (2005) (2)
- P.1.083 Efficacy of citalopram treatment in subjects with burning mouth syndrome with and without depressive disorders (2003) (1)
- Genetics of antioxidant defence (2008) (1)
- 0046 CHILDHOOD PSYCHOMOTOR DEVELOPMENT AND EARLY-ONSET SCHIZOPHRENIA COURSE (2006) (1)
- [Body image disturbance in anorexia nervosa]. (1997) (1)
- [The structure of temperament sixth year students of the medical faculty of the medical university]. (2010) (1)
- Hyperprolactinemia and bleeding following use of sertraline but not use of citalopram and paroxetine : a case report (2012) (1)
- P.3.c.023 Glycine plasma levels are not a useful predictor of recovery in patients treated with glycine and neuroleptics (2010) (1)
- [Depressive disorders and symptoms accompanying pegylated interferon alpha and ribavirin treatment of chronic hepatitis C patients]. (2008) (1)
- [Mental state of marijuana-smoking adolescents]. (1989) (1)
- Initial glycine serum level is not a predictor of the recovery resulting from glycine augmentation of antipsychotic treatment (2011) (1)
- [Neurodevelopmental schizophrenia: the concept of developmental origins of certain forms of schizophrenia]. (1997) (1)
- [Could we use a serum level of glycine as a prognostic factor of its efficacy in schizophrenic patients?]. (2010) (1)
- Assessment of independent risk factors of conversion into psychosis in the ultra-high risk state group of patients (2011) (1)
- [Attention abnormalities in patients with chronic hepatitis C after pegylated interferon alpha and ribavirin treatment]. (2008) (1)
- [The difference between obsessive-compulsive disorder in adolescence and in adults]. (2001) (0)
- The effects of therapeutic concentrations of amisulpride and risperidone on human plasma lipid peroxidation – in vitro studies (2012) (0)
- 1306 – The Comparison Of β-endorphin And Cgrp Levels In Patients With Severe Symptoms Of Schizophrenia And In Stable Mental State After Treatment (2013) (0)
- [Problems of neurotic disorders in children aged 7-12 years hospitalized at the Institute of Mental Hygiene, Military Medical Academy, 1967-1981]. (1985) (0)
- P.3.15 Peg-interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients (2008) (0)
- Clinical manifestation of interferon alpha-induced depression (2007) (0)
- P.1.e.002 Diffusion tensor imaging findings in early-onset schizophrenia patients (2010) (0)
- [Diagnosis and treatment of narcotic dependence in pregnant women and the neonatal abstinence syndrome in newborn infants]. (1988) (0)
- Patient knowledge about schizophrenia and treatment compliance (2002) (0)
- [Metabolic causes of bone mineralisation disorders in patients with anorexia nervosa]. (2005) (0)
- P.1.c.019 The effect of lithium on oxidant–antioxidant balance in vitro and in neuronal cell cultures (2011) (0)
- [The analysis of factors prior to positive symptoms relapse in schizophrenia]. (2002) (0)
- Epicatechin Inhibits Human Plasma Lipid Peroxidation Caused by Haloperidol In Vitro (2011) (0)
- P.3.c.045 Glycine augmentation of antipsychotic treatment may improve depressive symptomatology in schizophrenic patients (2012) (0)
- P0152 - “Breakwater”- The preventive and therapeutic programme for the first degree relatives of schizophrenic patients (2008) (0)
- P.3.d.017 The atypical and classical antypsychotic drugs affect adenosine diphosphate-induced platelet aggregation (2007) (0)
- P.3.a.018 Changes in antisaccadic test, gain and negative symptoms in schizophrenic patients treated with glycine (2008) (0)
- P.3.a.023 Infiuence of glycine on cognitive functions in schizophrenia (2006) (0)
- P.3.092 A comparative study of haloperidol and clozapine on lipid peroxidation in human plasma (in vitro) (2005) (0)
- P.3.d.022 The effects of quetiapine, olanzapine and haloperidol on human plasma lipid peroxidation in vitro (2009) (0)
- [Follow-up studies on social adjustment of children with chronic brain damage hospitalized at the pediatric department of the Lódź Medical Academy during the years 1967-1970]. (1980) (0)
- The correlation between BMI, weight loss, duration of emaciation and changes in ECG in patients with anorexia nervosa (2012) (0)
- [Haemostatic and fibrinolytic variables in women with anorexia nervosa]. (2005) (0)
- [Use of alprazolam in treatment of mental disorders]. (1995) (0)
- Do auditory verbal hallucinations have always a clinical significance ? (2013) (0)
- [Organic depressive disorders in children and adolescents]. (1991) (0)
- peg-interferon alpha and ribavirin (peg-IFNalpha/RBV) therapy may induce working memory disturbances in chronic hepatitis c (CHC) patients (2007) (0)
- [Declared management methods used by the Polish psychiatrists among a group of people with a high risk syndrome of psychosis development: results of the National Polish Questionnaire]. (2011) (0)
- [Depressive disorders in children and adolescents]. (1993) (0)
- P.5.a.003 Cognitive dysfunctions observed during pegylated interferon alpha and ribavirin therapy may persist after treatment discontinuation (2007) (0)
- P.3.a.013 Decreased bone mineral density in patients with schizophrenia treated with risperidone or olanzapine. (2007) (0)
- P.3.019 Impact of lithium on oxidative stress parameters in human plasma in vitro and neuroblastoma SH-SY5Y oxidative stress level and viability (2012) (0)
- Contents Vol. 63, 2011 (2011) (0)
- [Body dysmorphic disorder: clinical picture, diagnostic criteria, prevalence, course and treatment]. (1998) (0)
- [The effects of antipsychotic treatment on the hypothalamo-pituitary-gonadal (HPG) axis in patients with schizophrenia]. (2003) (0)
- Simultaneous use of sertraline and hormonal replacement therapy (HRT) in women with major depression during the menopausal period (2000) (0)
- P.3.a.015 Relation between working memory and negative symptoms and other factors in patients with first episode of schizophrenia (2007) (0)
- P.5.a.002 Peg-interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients (2007) (0)
- P.3.d.023 The effects of quetiapine and haloperidol on human plasma lipid peroxidation in vitro (2008) (0)
- [Etiopathogenesis, symptomatology and the course of depressive disorders in children and adolescents]. (1991) (0)
- [Panic disorders and panic-like disorders]. (1992) (0)
- exogenous polyunsaturated fatty acids may improve efficiency of selected cognitive functions (2009) (0)
- Hyperprolactinaemia in patients with schizophrenia treated with risperidone or olanzapine, correlations with age of patients and lengh of treatment (2007) (0)
- [Panic attacks and panic disorder. Diagnostic criteria, prevalence, etiopathogenesis, clinical presentation and treatment]. (1993) (0)
- [Mental status of subjects who 15 years ago (in childhood and/or puberty) were diagnosed with depressive disorders]. (2001) (0)
- [The role of obstetric complications in the pathogenesis of schizophrenia]. (2000) (0)
- P.3.d.018 The effects of the antipsychotic drugs on collagen-induced platelet aggregation in vitro (2007) (0)
- Subject Index Vol. 63, 2011 (2011) (0)
- [Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities]. (2005) (0)
- P.1.b.001 Gender -related differences in white matter structure in early-onset schizophrenia subjects (2011) (0)
- P.3.09 Comparison of bone metabolism between patients with restrictive and bulimic type of anorexia nervosa (2005) (0)
This paper list is powered by the following services:
